CCDC147 activators belong to a specialized class of chemical compounds that are characterized by their ability to modulate the activity of the protein encoded by the CCDC147 gene, also known as Coiled-Coil Domain Containing 147. The molecular nature of these activators can vary widely, encompassing small molecules, peptides, or other biologically relevant ligands that have been found to interact specifically with this protein. The coiled-coil domain is a structural motif that occurs in proteins and is typified by a supercoiling of α-helices, reminiscent of the strands of a rope. This structural feature is known to mediate protein-protein interactions and is integral to the function of CCDC147. The precise biochemical pathways and the physical interactions between CCDC147 and its activators are topics of interest in molecular biology and biochemistry, as they provide insight into the fundamental processes that regulate the function of this protein.
The study of CCDC147 activators involves a multidisciplinary approach, integrating techniques from synthetic chemistry for the creation and optimization of the activating compounds, biochemistry for the elucidation of the interaction between the activator and CCDC147, and molecular biology to understand the consequences of this activation on the protein's function. The activators are identified through various high-throughput screening methods or rational drug design processes, where their ability to interact with CCDC147 is evaluated. Once identified, these molecules are often subject to further structural modification to enhance their efficacy, specificity, and selectivity for CCDC147. Investigations into the structure-activity relationships of these compounds contribute significantly to the knowledge of how the activators exert their molecular effects. This research is supported by computational modeling and crystallography to visualize the interactions at an atomic level, alongside spectroscopic methods like NMR and mass spectrometry to characterize the binding dynamics and the structural integrity of the protein when engaged with its activators.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin is an adenylyl cyclase activator, which increases the levels of cyclic AMP (cAMP) within cells. Elevated cAMP activates protein kinase A (PKA), which can phosphorylate other proteins, possibly leading to the enhancement of CCDC147's functional roles in cellular processes. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a potent activator of protein kinase C (PKC). Activation of PKC can lead to the phosphorylation of target proteins, which may include CCDC147, thereby enhancing its activity within cellular signaling pathways. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels, which could activate calcium-dependent kinases and phosphatases, potentially modulating the activity of CCDC147. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol found in green tea with kinase inhibitory activity. This compound could influence signaling pathways involving CCDC147 by inhibiting kinases that negatively regulate its function. | ||||||
Oleic Acid | 112-80-1 | sc-200797C sc-200797 sc-200797A sc-200797B | 1 g 10 g 100 g 250 g | $37.00 $104.00 $580.00 $1196.00 | 10 | |
Oleic Acid is a monounsaturated fatty acid that can incorporate into cellular membranes and influence signaling pathways. It may modulate the activity of CCDC147 by affecting membrane fluidity and associated signaling cascades. | ||||||
Resveratrol | 501-36-0 | sc-200808 sc-200808A sc-200808B | 100 mg 500 mg 5 g | $80.00 $220.00 $460.00 | 64 | |
Resveratrol is a polyphenolic compound known to activate sirtuin 1 (SIRT1), which could indirectly enhance the activity of CCDC147 through deacetylation of proteins involved in CCDC147-related pathways. | ||||||
D-erythro-Sphingosine-1-phosphate | 26993-30-6 | sc-201383 sc-201383D sc-201383A sc-201383B sc-201383C | 1 mg 2 mg 5 mg 10 mg 25 mg | $165.00 $322.00 $570.00 $907.00 $1727.00 | 7 | |
S1P is a bioactive lipid that activates sphingosine-1-phosphate receptors, potentially influencing CCDC147 activity by modulating downstream signaling pathways such as PI3K/Akt. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid is a metabolite of vitamin A that binds to retinoic acid receptors and can influence gene expression. It could enhance CCDC147 activity by affecting transcription factors and coactivators in CCDC147-related gene regulatory networks. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor which may enhance CCDC147 activity by altering the PI3K/AKT pathway, resulting in a shift of cellular signaling that favors the activation of CCDC147. | ||||||
(±)-S-Nitroso-N-acetylpenicillamine | 79032-48-7 | sc-200319B sc-200319 sc-200319A | 10 mg 20 mg 100 mg | $74.00 $114.00 $374.00 | 18 | |
SNAP releases nitric oxide, which can activate guanylyl cyclase, increasing cGMP levels and influencing signaling pathways that could lead to the enhancement of CCDC147 activity. | ||||||